SELANK
Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed in Russia, studied for its potential anxiolytic and central nervous system modulation effects.
| Category | Pepitides |
|---|---|
| Strength | 10 mg / 3 ml |
| Research class | What it is and how it works • Composition: Derived from tuftine (a natural immunomodulatory fragment of the organism) combined with a Pro-Gly-Pro sequence that increases its resistance to enzymatic degradation. • Mechanism of action: It acts by modulating GABA-A receptors, in addition to influencing serotonin and dopamine pathways, and stimulating brain-derived neurotrophic factor (BDNF). • Common presentation: Focused on experimental studies and use in biohacking niches in the intranasal form (through the olfactory nerve and trigeminal nerve), with the proposal of generating calm without causing the typical sedation of benzodiazepines. |
| Class | Calm Peptide |
| Storage | 2–8 °C |
| Origin | Denmark |
Regulatory Status and Evidence • In Russia: It is registered and sold commercially as medicine/nasal drops. • In Brazil, the USA and the European Union: It is not registered as a drug approved by Anvisa or equivalent bodies. • Clinical evidence: Although there is preliminary research on anxiety, stress and cognitive function
For research use only